Revenue
2011
2012
| 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $250 | $1,750 | — | — |
| Research & development | $0 | $0 | $0 | $0 | $0 | — | — | — | — |
| Operating expenses | $228,068 | $316,410 | $65,417 | $38,808 | $122,089 | $20.5M | $3,608 | — | — |
| Operating income | — | — | −$64,416 | −$38,808 | −$122,089 | — | — | — | — |
| Net income | −$242,602 | −$1.7M | −$65,417 | −$13.8M | −$122,089 | −$20.5M | −$1,858 | −$993 | −$3,105 |
| Basic EPSper diluted share | $0.00 | -$0.03 | $0.00 | -$21.14 | -$0.05 | -$443.60 | -$5.81 | — | — |
| Diluted EPSper diluted share | $0.00 | -$0.03 | $0.00 | -$21.14 | -$0.05 | -$443.60 | -$5.81 | — | — |